Published in Lancet Infect Dis on April 12, 2011
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother (2013) 1.10
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines. Clin Vaccine Immunol (2012) 1.06
Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database. PLoS One (2012) 1.04
Biogenesis of outer membrane vesicles in Serratia marcescens is thermoregulated and can be induced by activation of the Rcs phosphorelay system. J Bacteriol (2012) 1.03
New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers. Indian J Med Res (2013) 0.96
Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development. Clin Vaccine Immunol (2014) 0.88
Estimating costs associated with a community outbreak of meningococcal disease in a colombian Caribbean city. J Health Popul Nutr (2014) 0.87
Meningococcal Vaccinations. Infect Dis Ther (2016) 0.82
Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases. J Immunol Res (2015) 0.80
Meningococcal carriage during a clonal meningococcal B outbreak in France. Eur J Clin Microbiol Infect Dis (2013) 0.78
Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries. PLoS One (2016) 0.77
Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis. PLoS One (2014) 0.76
Cellular Immune Responses in Humans Induced by Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Given Separately and in Combination. Clin Vaccine Immunol (2016) 0.75
Outer-membrane-vesicle vaccines: old but not forgotten. Lancet Infect Dis (2011) 0.75
Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet (2002) 10.26
Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science (2003) 7.49
Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis (2002) 5.75
Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med (2004) 3.93
Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis (2007) 3.31
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis (2013) 2.95
Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis (2002) 2.88
Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis (2007) 2.70
Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature. Arthritis Rheum (2008) 2.50
Impact of the 2003 heatwave on all-cause mortality in 9 French cities. Epidemiology (2006) 2.33
The relation between temperature, ozone, and mortality in nine French cities during the heat wave of 2003. Environ Health Perspect (2006) 2.06
Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol (2012) 1.94
Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis (2009) 1.92
Enhancing the MeSH thesaurus to retrieve French online health resources in a quality-controlled gateway. Health Info Libr J (2004) 1.72
Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases. Clin Infect Dis (2004) 1.69
Seroprevalence of varicella in the French population. Pediatr Infect Dis J (2006) 1.67
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis (2006) 1.66
The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J (2008) 1.65
Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J (2007) 1.64
Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine (2011) 1.60
Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol Microbiol (2002) 1.57
Hui and Walter's latent-class reference-free approach may be more useful in assessing agreement than diagnostic performance. J Clin Epidemiol (2005) 1.51
Mixed respiratory virus infections. J Clin Virol (2008) 1.46
Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review. Clin Infect Dis (2003) 1.46
Interdisciplinary treatment of ruptured cerebral aneurysms in elderly patients. J Neurosurg (2010) 1.44
Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health (2011) 1.43
Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon. Emerg Infect Dis (2002) 1.42
The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis (2003) 1.41
Management of severely injured children in road accidents in France: impact of the acute care organization on the outcome. Pediatr Crit Care Med (2009) 1.40
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother (2007) 1.40
[Function of French fellows in pediatric and neonatal intensive care units: a paradoxical organisation]. Arch Pediatr (2004) 1.39
Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine (2010) 1.37
Measles elimination efforts and 2008-2011 outbreak, France. Emerg Infect Dis (2013) 1.28
Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect Immun (2007) 1.28
The duality of virulence and transmissibility in Neisseria meningitidis. Trends Microbiol (2002) 1.28
Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis (2013) 1.27
Non-invasive ventilation as primary ventilatory support for infants with severe bronchiolitis. Intensive Care Med (2008) 1.26
Correlations between carbon metabolism and virulence in bacteria. Contrib Microbiol (2009) 1.25
Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G. J Biol Chem (2003) 1.25
Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. PLoS One (2012) 1.23
Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin Infect Dis (2003) 1.23
A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol Lett (2003) 1.17
The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine (2005) 1.17
Clostridium difficile has an original peptidoglycan structure with a high level of N-acetylglucosamine deacetylation and mainly 3-3 cross-links. J Biol Chem (2011) 1.17
Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages. J Immunol (2007) 1.16
International nomenclature for Corynebacterium diphtheriae ribotypes. Res Microbiol (2004) 1.15
Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine (2012) 1.15
Detailed structural analysis of the peptidoglycan of the human pathogen Neisseria meningitidis. J Biol Chem (2003) 1.15
The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine (2011) 1.14
Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill (2008) 1.12
Noninvasive ventilation and weaning in patients with chronic hypercapnic respiratory failure: a randomized multicenter trial. Am J Respir Crit Care Med (2011) 1.11
Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface. Infect Immun (2004) 1.11
Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer (2009) 1.11
Mycobacterium bovis BCG disrupts the interaction of Rab7 with RILP contributing to inhibition of phagosome maturation. J Leukoc Biol (2007) 1.11
Prevalence and diversity of Clostridium difficile strains in infants. J Med Microbiol (2011) 1.11
Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections. Antimicrob Agents Chemother (2003) 1.10
Influenza pandemic preparedness in France: modelling the impact of interventions. J Epidemiol Community Health (2006) 1.09
Short term effects of air pollution on hospitalizations for cardiovascular diseases in eight French cities: the PSAS program. Sci Total Environ (2007) 1.06
Influenza burden in children newborn to eleven months of age in a pediatric emergency department during the peak of an influenza epidemic. Pediatr Infect Dis J (2003) 1.06
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines. Clin Vaccine Immunol (2012) 1.06
Septicemia due to Pasteurella pneumotropica: 16S rRNA sequencing for diagnosis confirmation. J Clin Microbiol (2002) 1.05
A novel metal transporter mediating manganese export (MntX) regulates the Mn to Fe intracellular ratio and Neisseria meningitidis virulence. PLoS Pathog (2011) 1.04
Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S. J Immunol (2005) 1.03
Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex. Microbes Infect (2005) 1.03
The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso. Microbes Infect (2005) 1.02
Transcription regulators potentially controlled by HPr kinase/phosphorylase in Gram-negative bacteria. J Mol Microbiol Biotechnol (2003) 1.01
Meningococcal serogroup Y emergence in Europe: update 2011. Hum Vaccin Immunother (2012) 1.00
Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect Immun (2009) 0.99
Hospitalization of newborns and young infants for chickenpox in France. Eur J Pediatr (2010) 0.99
Influenza vaccination coverage of healthcare workers and residents and their determinants in nursing homes for elderly people in France: a cross-sectional survey. BMC Public Health (2010) 0.98
Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin. PLoS One (2011) 0.98
Burden of influenza, healthcare seeking behaviour and hygiene measures during the A(H1N1)2009 pandemic in France: a population based study. BMC Public Health (2012) 0.97
Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg Infect Dis (2008) 0.97
Standardized nonculture techniques recommended for European reference laboratories. FEMS Microbiol Rev (2006) 0.97
Macrolide-resistant Bordetella pertussis infection in newborn girl, France. Emerg Infect Dis (2012) 0.96
Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes. J Clin Microbiol (2010) 0.96
Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis. PLoS Pathog (2009) 0.96
Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France. J Infect Dis (2010) 0.95
Interaction of oncogenic papillomavirus E6 proteins with fibulin-1. Biochem Biophys Res Commun (2002) 0.94
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2012) 0.94
Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Microbiology (2011) 0.93
Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine. BMC Microbiol (2014) 0.93